Cargando…
Nasal shedding of vaccine viruses after immunization with a Russian‐backbone live attenuated influenza vaccine in India
BACKGROUND: We present post‐vaccination nasal shedding findings from the phase IV, community‐based, triple‐blinded RCT conducted to assess efficacy of trivalent LAIV and inactivated influenza vaccines in rural north India. METHODS: Children aged 2–10 years received LAIV or intranasal placebo across...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293783/ https://www.ncbi.nlm.nih.gov/pubmed/37380175 http://dx.doi.org/10.1111/irv.13149 |
_version_ | 1785063064789319680 |
---|---|
author | Dar, Lalit Krishnan, Anand Kumar, Ramesh Dhakad, Shivram Choudekar, Avinash Bagga, Sumedha Sharma, Amrit Kumar, Amit Jethani, Jyoti Saha, Siddhartha Amarchand, Ritvik Kumar, Rakesh Choudhary, Aashish Narayan, Venkatesh Vinayak Gopal, Giridara Lafond, Kathryn E. Lindstrom, Stephen |
author_facet | Dar, Lalit Krishnan, Anand Kumar, Ramesh Dhakad, Shivram Choudekar, Avinash Bagga, Sumedha Sharma, Amrit Kumar, Amit Jethani, Jyoti Saha, Siddhartha Amarchand, Ritvik Kumar, Rakesh Choudhary, Aashish Narayan, Venkatesh Vinayak Gopal, Giridara Lafond, Kathryn E. Lindstrom, Stephen |
author_sort | Dar, Lalit |
collection | PubMed |
description | BACKGROUND: We present post‐vaccination nasal shedding findings from the phase IV, community‐based, triple‐blinded RCT conducted to assess efficacy of trivalent LAIV and inactivated influenza vaccines in rural north India. METHODS: Children aged 2–10 years received LAIV or intranasal placebo across 2015 and 2016, as per initial allocation. On days 2 and 4 post‐vaccination, trained study nurses collected nasal swabs from randomly selected subset of trial participants based on operational feasibility, accounting for 10.0% and 11.4% of enrolled participants in 2015 and 2016, respectively. Swabs were collected in viral transport medium and transported under cold chain to laboratory for testing by reverse transcriptase real‐time polymerase chain reaction. RESULTS: In year 1, on day 2 post‐vaccination, 71.2% (74/104) of LAIV recipients shed at least one of vaccine virus strains compared to 42.3% (44/104) on day 4. During year 1, on day 2 post‐vaccination, LAIV‐A(H1N1)pdm09 was detected in nasal swabs of 12% LAIV recipients, LAIV‐A(H3N2) in 41%, and LAIV‐B in 59%. In year 2, virus shedding was substantially lower; 29.6% (32/108) of LAIV recipients shed one of the vaccine virus strains on day 2 compared to 21.3% on day 4 (23/108). CONCLUSION: At day 2 post‐vaccination in year 1, two‐thirds of LAIV recipients were shedding vaccine viruses. Shedding of vaccine viruses varied between strains and was lower in year 2. More research is needed to determine the reason for lower virus shedding and vaccine efficacy for LAIV‐A(H1N1)pdm09. |
format | Online Article Text |
id | pubmed-10293783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102937832023-06-28 Nasal shedding of vaccine viruses after immunization with a Russian‐backbone live attenuated influenza vaccine in India Dar, Lalit Krishnan, Anand Kumar, Ramesh Dhakad, Shivram Choudekar, Avinash Bagga, Sumedha Sharma, Amrit Kumar, Amit Jethani, Jyoti Saha, Siddhartha Amarchand, Ritvik Kumar, Rakesh Choudhary, Aashish Narayan, Venkatesh Vinayak Gopal, Giridara Lafond, Kathryn E. Lindstrom, Stephen Influenza Other Respir Viruses Original Articles BACKGROUND: We present post‐vaccination nasal shedding findings from the phase IV, community‐based, triple‐blinded RCT conducted to assess efficacy of trivalent LAIV and inactivated influenza vaccines in rural north India. METHODS: Children aged 2–10 years received LAIV or intranasal placebo across 2015 and 2016, as per initial allocation. On days 2 and 4 post‐vaccination, trained study nurses collected nasal swabs from randomly selected subset of trial participants based on operational feasibility, accounting for 10.0% and 11.4% of enrolled participants in 2015 and 2016, respectively. Swabs were collected in viral transport medium and transported under cold chain to laboratory for testing by reverse transcriptase real‐time polymerase chain reaction. RESULTS: In year 1, on day 2 post‐vaccination, 71.2% (74/104) of LAIV recipients shed at least one of vaccine virus strains compared to 42.3% (44/104) on day 4. During year 1, on day 2 post‐vaccination, LAIV‐A(H1N1)pdm09 was detected in nasal swabs of 12% LAIV recipients, LAIV‐A(H3N2) in 41%, and LAIV‐B in 59%. In year 2, virus shedding was substantially lower; 29.6% (32/108) of LAIV recipients shed one of the vaccine virus strains on day 2 compared to 21.3% on day 4 (23/108). CONCLUSION: At day 2 post‐vaccination in year 1, two‐thirds of LAIV recipients were shedding vaccine viruses. Shedding of vaccine viruses varied between strains and was lower in year 2. More research is needed to determine the reason for lower virus shedding and vaccine efficacy for LAIV‐A(H1N1)pdm09. John Wiley and Sons Inc. 2023-06-26 /pmc/articles/PMC10293783/ /pubmed/37380175 http://dx.doi.org/10.1111/irv.13149 Text en © 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Dar, Lalit Krishnan, Anand Kumar, Ramesh Dhakad, Shivram Choudekar, Avinash Bagga, Sumedha Sharma, Amrit Kumar, Amit Jethani, Jyoti Saha, Siddhartha Amarchand, Ritvik Kumar, Rakesh Choudhary, Aashish Narayan, Venkatesh Vinayak Gopal, Giridara Lafond, Kathryn E. Lindstrom, Stephen Nasal shedding of vaccine viruses after immunization with a Russian‐backbone live attenuated influenza vaccine in India |
title | Nasal shedding of vaccine viruses after immunization with a Russian‐backbone live attenuated influenza vaccine in India |
title_full | Nasal shedding of vaccine viruses after immunization with a Russian‐backbone live attenuated influenza vaccine in India |
title_fullStr | Nasal shedding of vaccine viruses after immunization with a Russian‐backbone live attenuated influenza vaccine in India |
title_full_unstemmed | Nasal shedding of vaccine viruses after immunization with a Russian‐backbone live attenuated influenza vaccine in India |
title_short | Nasal shedding of vaccine viruses after immunization with a Russian‐backbone live attenuated influenza vaccine in India |
title_sort | nasal shedding of vaccine viruses after immunization with a russian‐backbone live attenuated influenza vaccine in india |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293783/ https://www.ncbi.nlm.nih.gov/pubmed/37380175 http://dx.doi.org/10.1111/irv.13149 |
work_keys_str_mv | AT darlalit nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT krishnananand nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT kumarramesh nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT dhakadshivram nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT choudekaravinash nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT baggasumedha nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT sharmaamrit nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT kumaramit nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT jethanijyoti nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT sahasiddhartha nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT amarchandritvik nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT kumarrakesh nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT choudharyaashish nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT narayanvenkateshvinayak nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT gopalgiridara nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT lafondkathryne nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia AT lindstromstephen nasalsheddingofvaccinevirusesafterimmunizationwitharussianbackboneliveattenuatedinfluenzavaccineinindia |